PMCB·71715X203·US·equity·Healthcare - Biotechnology-13D/G
PMCB (PHARMACYTE BIOTECH INC) is held by 17 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($239,243), GEODE CAPITAL MANAGEMENT, LLC ($130,200), RENAISSANCE TECHNOLOGIES LLC ($37,595). Net institutional sentiment: Mixed.
See how PMCB's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer